GENEVA, Sept 13: The WHO said Friday it had for the first time prequalified an mpox vaccine -- a move expected to speed up access to the jabs to fight an epidemic raging in Africa.
The announcement came on the heels of the arrival of the first MVA-BN vaccines to the Democratic Republic of Congo, the epicentre of the epidemic.
"This first prequalification of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future," WHO chief Tedros Adhanom Ghebreyesus said in a statement.
"We now need urgent scale up in procurement, donations and rollout to ensure equitable access to vaccines where they are needed most... to prevent infections, stop transmission and save lives."
WHO's prequalification listing is used to evaluate the quality, safety and efficacy of medical products like vaccines, paving the way for the United Nations and other international agencies to procure them.
The list is also used by lower-income countries without the means to carry out their evaluations to fast-track procurement approvals.
"The WHO prequalification of the MVA-BN vaccine will help accelerate ongoing procurement of the mpox vaccines by governments and international agencies... on the frontlines of the ongoing emergency in Africa and beyond," said Yukiko Nakatani, WHO's assistant chief in charge of access to medicines and health products. —AFP
